Blackstone Inc
CGON icon

Blackstone Inc’s CG Oncology CGON Stock Holding History

Blackstone Inc’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.34M Buy
+64,128
New +$3.63M 0.02% 133
2024
Q2 		– Sell
-25,000
Closed -$1.1M – 182
2024
Q1 		$1.1M Buy
+25,000
New +$1.02M ﹤0.01% 138

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Blackstone Inc's CGON Position: Q1 2026 in Review

Blackstone Inc opened a new position in CG Oncology (CGON) in Q1 2026: 64,128 shares worth $4.34M. The stake represents 0.02% of the portfolio and ranks #133 among its holdings. This is a return to the name: Blackstone Inc previously reported a position in CGON as recently as Q1 2024.

Blackstone Inc first reported a position in CGON in Q1 2024 and has held it in 2 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Blackstone Inc held 64,128 shares of CG Oncology worth $4.34M as of Q1 2026.
  • CG Oncology was a new Blackstone Inc position in Q1 2026.
  • CG Oncology made up 0.02% of Blackstone Inc's portfolio in Q1 2026, its #133 holding.
  • Blackstone Inc first reported a position in CG Oncology in Q1 2024 and has held it in 2 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Blackstone Inc's 13F filing for Q1 2026, filed 15 May 2026.